Validation and adaptation of the Indonesian version of thyroid cancer quality of life questionnaire
DOI:
https://doi.org/10.13181/mji.oa.257639Keywords:
questionnaire, reliability and validity, thyroid cancerAbstract
BACKGROUND The rising incidence of thyroid cancer in Indonesia has become a public health concern. This study was aimed to evaluate the validity of the thyroid cancer-quality of life-Indonesian version (ThyCa-QoL-ID).
METHODS This cross-sectional study involved translating the original ThyCa-QoL questionnaire from English to Indonesian (T1), which was then back-translated into English (T2). The T2 questionnaire was compared with the original ThyCa-QoL questionnaire to refine T1, resulting in T3. The T3 questionnaire underwent cognitive and transcultural validation through individual assessment and focus group discussions with 10 doctors and 10 nurses at Cipto Mangunkusumo Hospital and St. Carolus Hospital, and 5 patients with thyroid cancer from St. Carolus Hospital. This process ensured cultural, language, and literacy adaptation processes for patients across different age groups.
RESULTS The ThyCa-QoL questionnaire demonstrated validity, with all questions showing correlation calculation (r) above the r table. Test-retest reliability was measured by calculating the intraclass correlation coefficient for each question on the ThyCa-QoL questionnaire. The reliability test can be seen in the value of Cronbach’s alpha (0.915), exceeding the standard Cronbach’s alpha value standard (0.6).
CONCLUSIONS The ThyCa-QoL-ID was confirmed as a valid and reliable tool for assessing the QoL of patients with thyroid cancer in Indonesia.
Downloads
References
van Velsen EF, Massolt ET, Heersema H, Kam BL, van Ginhoven TM, Visser WE, et al. Longitudinal analysis of quality of life in patients treated for differentiated thyroid cancer. Eur J Endocrinol. 2019;181(6):671−9. https://doi.org/10.1530/EJE-19-0550
Wu X, Liu H, He J, Hu C, Xie W, Luo B, et al. Postoperative quality of life in patients treated for thyroid cancer with transoral endoscopic and open surgery. Sci Rep. 2025;15(7257). https://doi.org/10.1038/s41598-025-91291-7
Sanabria Á, Gómez Ó. Adaptation and validation of the Spanish version of the thyroid-cancer specific Thyca-QoL scale: a cross-sectional study. Rev Colomb Cir. 2023;38(4):613-23. https://doi.org/10.30944/20117582.2177
Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ Jr, et al. 2021 American Thyroid Association Guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2021;31(3):337−86. Erratum in: Thyroid. 2021;31(10):1606−7. https://doi.org/10.1089/thy.2020.0944
Walshaw EG, Smith M, Kim D, Wadsley J, Kanatas A, Rogers SN. Systematic review of health-related quality of life following thyroid cancer. Tumori. 2022;108(4):291−314. https://doi.org/10.1177/03008916211025098
Hu ZY, Gou JX, Cai M, Zhang YE. Translation and validation of M.D. Anderson Symptom Inventory-Thyroid Cancer module in Chinese thyroid cancer patients: a cross-sectional and methodological study. BMC Cancer. 2022;22(1):924. https://doi.org/10.1186/s12885-022-09995-2
Kim MJ, Moon JH, Lee EK, Song YS, Jung KY, Lee JY, et al. Active surveillance for low-risk thyroid cancers: a review of current practice guidelines. Endocrinol Metab (Seoul). 2024;39(1):47−60. https://doi.org/10.3803/EnM.2024.1937
Ha EJ, Chung SR, Na DG, Ahn HS, Chung J, Lee JY, et al. 2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J Radiol. 2021;22(12):2094−123. https://doi.org/10.3348/kjr.2021.0713
Uslar V, Becker C, Weyhe D, Tabriz N. Thyroid disease-specific quality of life questionnaires - a systematic review. Endocrinol Diabetes Metab. 2022;5(5):e357. https://doi.org/10.1002/edm2.357
Xue S, Wang P, Hurst ZA, Chang YS, Chen G. Active surveillance for papillary thyroid microcarcinoma: challenges and prospects. Front Endocrinol (Lausanne). 2018;9:736. https://doi.org/10.3389/fendo.2018.00736
Büttner M, Locati LD, Pinto M, Araújo C, Tomaszewska IM, Kiyota N, et al. Quality of life in patients with hypoparathyroidism after treatment for thyroid cancer. J Clin Endocrinol Metab. 2020;105(12):dgaa597. https://doi.org/10.1210/clinem/dgaa597
Büttner M, Hinz A, Singer S, Musholt TJ. Quality of life of patients more than 1 year after surgery for thyroid cancer. Hormones (Athens). 2020;19(2):233−43. https://doi.org/10.1007/s42000-020-00186-x
Sanjari M, Esmaeeli M, Ahmadipour H. Thyroid cancer-specific health-related quality of life questionnaire: psychometric properties of the Persian version. Int J Prev Med. 2022;13:53. https://doi.org/10.4103/ijpvm.IJPVM_77_20
Watt T, Christoffersen T, Brogaard MB, Bjorner JB, Bentzen J, Hahn CH, et al. Quality of life in thyroid cancer. Best Pract Res Clin Endocrinol Metab. 2023;37(1):101732. https://doi.org/10.1016/j.beem.2023.101732
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Laurentius Aswin Pramono, Hamzah Shatri, Imam Subekti, Nurhayati Adnan Prihartono, Ratna Djuwita Hatma, Meily Kurniawidjaja, Sabarinah Prasetyo, Felicia Kurniawan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
